Trials / Conditions / Unresectable Undifferentiated Pleomorphic Sarcoma

Unresectable Undifferentiated Pleomorphic Sarcoma

5 registered clinical trials studyying Unresectable Undifferentiated Pleomorphic Sarcoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Po NCT06422806	National Cancer Institute (NCI)	Phase 3
Recruiting	Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposert NCT05711615	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advan NCT05836571	National Cancer Institute LAO	Phase 2
Terminated	Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleo NCT05017103	M.D. Anderson Cancer Center	Phase 2
Completed	Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot B NCT03009201	OHSU Knight Cancer Institute	Phase 1